MedTrace Logo

BFA Treatment of Pain

NCT04464954 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-04-04

Study results available
· View outcomes & findings →

Summary

The aim of this pilot study is to conduct an unblinded pilot randomized clinical study on the effectiveness and tolerability of auricular semi-permanent (ASP) vs intradermal (long), and pyonex needles in Battlefield Acupuncture (BFA) for the treatment of pain.

Conditions

Interventions

DEVICE

Auricular semi-permanent (ASP gold) needles

ASP semi-permanent Battlefield Acupuncture needles are semi-permanent needles that will remain in subject ears for 2-8 days and will be allowed to fall out on their own

DEVICE

Intradermal (long) needles using J-type No. 2 (.18)x 15mm

Intradermal (long) needles will remain in subject ears for 15-30 minutes and will be removed by a member of the study staff.

DEVICE

Pyonex needles (Seirin Yellow 0.2 x 0.6mm)

Pyonex needles will remain in subject ears for 2-21 days and allowed to fall out on their own.

Sponsors & Collaborators

  • Paul Crawford

    lead FED

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-04-20
Completion
2021-04-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04464954 on ClinicalTrials.gov